Thursday, May 21, 2026

2:30 PM - 3:15 PM

---

Details

Surgical robotics has transitioned from experimental promise to mainstream expectation, yet the path from OR excitement to Hospital P&L justification remains fraught with complexity. This panel convenes four critical voices across the commercialization continuum: a surgeon quantifying clinical outcomes beyond "minimally invasive" marketing claims, a startup founder navigating the innovation-to-revenue gauntlet, a MedTech executive who scaled systems across hospital networks, and a Hospital decision-maker deciding which million-dollar platforms earn capital allocation. Together, they'll dissect the uncomfortable economics behind the hype: procedure reimbursement realities, utilization rate thresholds for ROI, competitive dynamics reshaping the post-Intuitive landscape, and whether surgical robotics represents genuine value creation or beautifully engineered cost centers. The truth about who wins financially in 2026 and beyond.

---

Speaker